Quick Answer
ImmunityBio, Inc. reported Shares Outstanding of 1.01 billion shares for fiscal year 2025.
ImmunityBio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.01B | +18.6% |
| 2024 | 852.90M | +27.1% |
| 2023 | 670.87M | +59.1% |
| 2022 | 421.57M | +6.0% |
| 2021 | 397.83M | +4.1% |
| 2020 | 382.24M | +288.2% |
| 2019 | 98.46M | +24.5% |
| 2018 | 79.09M | +0.1% |
| 2017 | 79.02M | -3.6% |
| 2016 | 81.98M | +0.8% |
| 2015 | 81.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 984.97M | +41.3% | +7.6% |
| June 30, 2025 | 915.63M | +32.4% | +7.3% |
| March 31, 2025 | 853.56M | +26.1% | +0.1% |
| December 31, 2024 | 852.90M | +27.1% | +22.4% |
| September 30, 2024 | 696.83M | +4.4% | +0.7% |
| June 30, 2024 | 691.79M | +57.0% | +2.2% |
| March 31, 2024 | 677.00M | +60.6% | +0.9% |
| December 31, 2023 | 670.87M | +59.1% | +0.5% |
- ImmunityBio, Inc. showed an increase of +18.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, ImmunityBio, Inc.’s shares outstanding has grown by 1144.3% (from 81.31 million shares to 1.01 billion shares).
- The most recent figure is from ImmunityBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: